
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $1.6B | $1.9B | $1.9B | $1.7B | $1.9B | |
Revenue Growth (YoY) | -5.33% | 18.34% | -0.47% | -13.66% | 13.24% | |
Cost of Revenues | $1.3B | $1.5B | $1.5B | $1.5B | $1.5B | |
Gross Profit | $351.2M | $446.2M | $391.1M | $164.9M | $359.3M | |
Gross Profit Margin | 21.43% | 23.01% | 20.26% | 9.9% | 19.04% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $251.8M | $248.9M | $231.3M | $211.2M | $225.6M | |
Other Inc / (Exp) | -$3.6M | -$12.9M | -$2.4M | -$5.3M | $65.7M | |
Operating Expenses | $250.4M | $260.7M | $243M | $222.3M | $238M | |
Operating Income | $100.8M | $185.5M | $148.1M | -$57.4M | $121.3M | |
Net Interest Expenses | $17.2M | $19.2M | $11.8M | $10.2M | $37.4M | |
EBT. Incl. Unusual Items | $80M | $153.4M | $133.9M | -$72.9M | $149.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $16.1M | $40.5M | $29.4M | -$23.8M | $63.4M | |
Net Income to Company | $63.9M | $112.9M | $104.5M | -$49.1M | $86.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $63.9M | $112.9M | $104.5M | -$49.1M | $86.2M | |
Basic EPS (Cont. Ops) | $0.55 | $0.98 | $0.90 | -$0.43 | $0.75 | |
Diluted EPS (Cont. Ops) | $0.55 | $0.98 | $0.90 | -$0.43 | $0.75 | |
Weighted Average Basic Share | $115.6M | $115.5M | $115.5M | $115.1M | $115M | |
Weighted Average Diluted Share | $115.6M | $115.5M | $115.5M | $115.1M | $115M | |
EBITDA | $163.6M | $230.9M | $207M | -$2.7M | $256.9M | |
EBIT | $99M | $173M | $150.8M | -$55.8M | $192.5M | |
Revenue (Reported) | $1.6B | $1.9B | $1.9B | $1.7B | $1.9B | |
Operating Income (Reported) | $100.8M | $185.5M | $148.1M | -$57.4M | $121.3M | |
Operating Income (Adjusted) | $99M | $173M | $150.8M | -$55.8M | $192.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $465M | $562.9M | $426.3M | $478.8M | $489.8M | |
Revenue Growth (YoY) | 10.45% | 21.05% | -24.27% | 12.32% | 2.3% | |
Cost of Revenues | $369.3M | $413.6M | $395.5M | $407.3M | $383M | |
Gross Profit | $95.7M | $149.3M | $30.8M | $71.5M | $106.8M | |
Gross Profit Margin | 20.58% | 26.52% | 7.23% | 14.93% | 21.81% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $58M | $61.4M | $53.2M | $54.2M | $61.6M | |
Other Inc / (Exp) | -$4M | -$4.6M | $3.8M | $5.8M | -$5.8M | |
Operating Expenses | $61.2M | $64.5M | $54.5M | $57.8M | $64.1M | |
Operating Income | $34.5M | $84.8M | -$23.7M | $13.7M | $42.7M | |
Net Interest Expenses | $4.9M | $4.4M | $2.2M | $7.9M | $11.2M | |
EBT. Incl. Unusual Items | $25.6M | $75.8M | -$22.1M | $11.6M | $25.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $6M | $18.3M | -$6.9M | $3.5M | $7.6M | |
Net Income to Company | $19.6M | $57.5M | -$15.2M | $8.1M | $18.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $19.6M | $57.5M | -$15.2M | $8.1M | $18.1M | |
Basic EPS (Cont. Ops) | $0.17 | $0.50 | -$0.13 | $0.07 | $0.16 | |
Diluted EPS (Cont. Ops) | $0.17 | $0.50 | -$0.13 | $0.07 | $0.16 | |
Weighted Average Basic Share | $115.5M | $115.5M | $115.3M | $115M | $115M | |
Weighted Average Diluted Share | $115.5M | $115.5M | $115.3M | $115M | $115M | |
EBITDA | $45M | $94.6M | -$3.9M | $32.8M | $52.2M | |
EBIT | $30.6M | $80.3M | -$17.9M | $20.8M | $37.3M | |
Revenue (Reported) | $465M | $562.9M | $426.3M | $478.8M | $489.8M | |
Operating Income (Reported) | $34.5M | $84.8M | -$23.7M | $13.7M | $42.7M | |
Operating Income (Adjusted) | $30.6M | $80.3M | -$17.9M | $20.8M | $37.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1.7B | $2B | $1.8B | $1.7B | $1.9B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1.3B | $1.5B | $1.5B | $1.5B | $1.5B | |
Gross Profit | $358.8M | $499.8M | $272.6M | $205.6M | $394.6M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $236.9M | $252.3M | $223.1M | $212.2M | $233M | |
Other Inc / (Exp) | -$34.5M | -$13.5M | $6M | -$3.3M | $54.1M | |
Operating Expenses | $235.4M | $264M | $233M | $225.6M | $244.3M | |
Operating Income | $123.4M | $235.8M | $39.6M | -$20M | $150.3M | |
Net Interest Expenses | $18.7M | $18.7M | $9.6M | $15.9M | $40.7M | |
EBT. Incl. Unusual Items | $70.2M | $203.6M | $36M | -$39.2M | $163.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $13.7M | $52.8M | $4.2M | -$13.4M | $67.5M | |
Net Income to Company | $56.5M | $150.8M | $31.8M | -$25.8M | $96.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $56.5M | $150.8M | $31.8M | -$25.8M | $96.2M | |
Basic EPS (Cont. Ops) | $0.49 | $1.31 | $0.27 | -$0.23 | $0.83 | |
Diluted EPS (Cont. Ops) | $0.49 | $1.31 | $0.27 | -$0.23 | $0.83 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $152.1M | $280.5M | $108.5M | $34M | $276.3M | |
EBIT | $89.6M | $222.7M | $52.6M | -$17.1M | $209M | |
Revenue (Reported) | $1.7B | $2B | $1.8B | $1.7B | $1.9B | |
Operating Income (Reported) | $123.4M | $235.8M | $39.6M | -$20M | $150.3M | |
Operating Income (Adjusted) | $89.6M | $222.7M | $52.6M | -$17.1M | $209M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $465M | $562.9M | $426.3M | $478.8M | $489.8M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $369.3M | $413.6M | $395.5M | $407.3M | $383M | |
Gross Profit | $95.7M | $149.3M | $30.8M | $71.5M | $106.8M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $58M | $61.4M | $53.2M | $54.2M | $61.6M | |
Other Inc / (Exp) | -$4M | -$4.6M | $3.8M | $5.8M | -$5.8M | |
Operating Expenses | $61.2M | $64.5M | $54.5M | $57.8M | $64.1M | |
Operating Income | $34.5M | $84.8M | -$23.7M | $13.7M | $42.7M | |
Net Interest Expenses | $4.9M | $4.4M | $2.2M | $7.9M | $11.2M | |
EBT. Incl. Unusual Items | $25.6M | $75.8M | -$22.1M | $11.6M | $25.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $6M | $18.3M | -$6.9M | $3.5M | $7.6M | |
Net Income to Company | $19.6M | $57.5M | -$15.2M | $8.1M | $18.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $19.6M | $57.5M | -$15.2M | $8.1M | $18.1M | |
Basic EPS (Cont. Ops) | $0.17 | $0.50 | -$0.13 | $0.07 | $0.16 | |
Diluted EPS (Cont. Ops) | $0.17 | $0.50 | -$0.13 | $0.07 | $0.16 | |
Weighted Average Basic Share | $115.5M | $115.5M | $115.3M | $115M | $115M | |
Weighted Average Diluted Share | $115.5M | $115.5M | $115.3M | $115M | $115M | |
EBITDA | $45M | $94.6M | -$3.9M | $32.8M | $52.2M | |
EBIT | $30.6M | $80.3M | -$17.9M | $20.8M | $37.3M | |
Revenue (Reported) | $465M | $562.9M | $426.3M | $478.8M | $489.8M | |
Operating Income (Reported) | $34.5M | $84.8M | -$23.7M | $13.7M | $42.7M | |
Operating Income (Adjusted) | $30.6M | $80.3M | -$17.9M | $20.8M | $37.3M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $355.3M | $406M | $327.8M | $194.7M | $106.7M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $294.8M | $326.3M | $220.3M | $273.6M | $269.2M | |
Inventory | $519M | $432.3M | $608.7M | $564.6M | $656.7M | |
Prepaid Expenses | $19M | -- | -- | -- | -- | |
Other Current Assets | -- | $38.5M | $48.6M | $43.4M | $47M | |
Total Current Assets | $1.2B | $1.3B | $1.2B | $1.1B | $1.1B | |
Property Plant And Equipment | $550.7M | $523.3M | $506M | $505.6M | $714.7M | |
Long-Term Investments | $105.5M | $106.1M | $116.1M | $113.2M | $3.4M | |
Goodwill | -- | -- | -- | -- | $2.6M | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $11.2M | $18.6M | $18.1M | $18.5M | $32.4M | |
Total Assets | $2B | $2B | $1.9B | $1.8B | $1.9B | |
Accounts Payable | $111M | $143.6M | $177.2M | $218.7M | $232.4M | |
Accrued Expenses | $70.4M | $80.7M | $85.5M | $76.8M | $94.8M | |
Current Portion Of Long-Term Debt | $700K | $1.4M | $1.1M | -- | $78.3M | |
Current Portion Of Capital Lease Obligations | $6.7M | $3.7M | $3.8M | $3.9M | $3.5M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $260.2M | $288.8M | $326.7M | $370.8M | $476.6M | |
Long-Term Debt | $486.7M | $449.8M | $424.1M | $440.9M | $429.1M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.2B | $1.1B | $977.2M | $1B | $1.1B | |
Common Stock | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | |
Other Common Equity Adj | -$448.2M | -$404.1M | -$331.5M | -$341.1M | -$363.5M | |
Common Equity | $796.5M | $870.2M | $957.2M | $808.3M | $817M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $796.5M | $870.2M | $957.2M | $808.3M | $817M | |
Total Liabilities and Equity | $2B | $2B | $1.9B | $1.8B | $1.9B | |
Cash and Short Terms | $355.3M | $406M | $327.8M | $194.7M | $106.7M | |
Total Debt | $487.4M | $451.2M | $425.2M | $440.9M | $507.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $373.6M | $350M | $177.8M | $120.7M | $20.5M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $314.7M | $374.1M | $261.2M | $330.8M | $338.4M | |
Inventory | $473M | $464.2M | $612.7M | $475.8M | $699.8M | |
Prepaid Expenses | $13.6M | $47.1M | -- | -- | -- | |
Other Current Assets | -- | -- | $41M | $37.9M | $47.1M | |
Total Current Assets | $1.2B | $1.3B | $1.1B | $984.7M | $1.1B | |
Property Plant And Equipment | $531.7M | $525.3M | $511.2M | $483.4M | $726.4M | |
Long-Term Investments | $109.7M | $110M | $116.1M | $111.2M | $2.4M | |
Goodwill | -- | -- | -- | -- | $2.6M | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $11.7M | $19.1M | $18.2M | $18.3M | $34.5M | |
Total Assets | $2B | $2B | $1.8B | $1.7B | $1.9B | |
Accounts Payable | $132M | $132.5M | $144.6M | $143.9M | $205.2M | |
Accrued Expenses | $42.9M | $11.1M | $58.7M | $10.5M | $10.2M | |
Current Portion Of Long-Term Debt | $700K | $1.4M | $900K | -- | $81.2M | |
Current Portion Of Capital Lease Obligations | $6.3M | $3.9M | $3.7M | $3.6M | $3.9M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $255.2M | $281.1M | $259.7M | $267.9M | $430.3M | |
Long-Term Debt | $465.9M | $443.8M | $433.5M | $426.9M | $476M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.2B | $1.1B | $919.4M | $905M | $1.1B | |
Common Stock | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M | |
Other Common Equity Adj | -$442.6M | -$395.2M | -$338.1M | -$361.2M | -$345.8M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $800.9M | $913.6M | $912.1M | $774.4M | $847M | |
Total Liabilities and Equity | $2B | $2B | $1.8B | $1.7B | $1.9B | |
Cash and Short Terms | $373.6M | $350M | $177.8M | $120.7M | $20.5M | |
Total Debt | $466.6M | $445.2M | $434.4M | $426.9M | $557.2M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $63.9M | $112.9M | $104.5M | -$49.1M | $86.2M | |
Depreciation & Amoritzation | $64.6M | $57.9M | $56.2M | $53.1M | $64.4M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$4.7M | -$58.6M | $85.7M | -$43.9M | -$8.4M | |
Change in Inventories | $13.3M | $65.8M | -$198.4M | $56.3M | -$43.1M | |
Cash From Operations | $102.5M | $206.5M | $81.7M | $5.5M | $72.5M | |
Capital Expenditures | $62.8M | $58.6M | $63.2M | $47.4M | $29.5M | |
Cash Acquisitions | -- | -- | -- | -- | -$156.8M | |
Cash From Investing | -$61.3M | -$58.6M | -$63.1M | -$47.4M | -$186.3M | |
Dividends Paid (Ex Special Dividend) | -$83.2M | -$83.2M | -$87.8M | -$87.5M | -$55.2M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | $292.5M | |
Long-Term Debt Repaid | -$1.1M | -$1.4M | -$1.3M | -$1.1M | -$201.5M | |
Repurchase of Common Stock | -$1M | -$200K | -$2.3M | -$2.9M | -- | |
Other Financing Activities | -- | -$1.9M | -$100K | -$100K | -$9.3M | |
Cash From Financing | -$85.3M | -$86.7M | -$91.5M | -$91.6M | $26.5M | |
Beginning Cash (CF) | $392.3M | $362M | $412.6M | $334.6M | $202.1M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$44.1M | $61.2M | -$72.9M | -$133.5M | -$87.3M | |
Ending Cash (CF) | $362M | $412.6M | $334.6M | $202.1M | $114.7M | |
Levered Free Cash Flow | $39.7M | $147.9M | $18.5M | -$41.9M | $43M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $25.7M | $45.9M | -$8.2M | $19.5M | -- | |
Depreciation & Amoritzation | $14.4M | $14.1M | $12.8M | $19.4M | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$7.2M | -$17.4M | -$21.8M | -$23.3M | -- | |
Change in Inventories | $48.8M | $2.5M | $70.7M | $24.6M | -- | |
Cash From Operations | $21.4M | $67.9M | $33.2M | $38.2M | -- | |
Capital Expenditures | $10.4M | $30.5M | $33.9M | $3.4M | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$10.4M | -$16.2M | -$17.5M | -$3.4M | -- | |
Dividends Paid (Ex Special Dividend) | -$20.8M | -$22M | -$21.9M | -$21.8M | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$200K | -$100K | -$200K | -- | -- | |
Repurchase of Common Stock | -- | -- | -$1.5M | -- | -- | |
Other Financing Activities | -$1.8M | -- | -- | -$900K | -- | |
Cash From Financing | -$22.8M | -$22.1M | -$23.6M | -$22.7M | -- | |
Beginning Cash (CF) | $379.9M | $356.2M | $184.2M | $127.3M | -- | |
Foreign Exchange Rate Adjustment | $2.1M | -$8.3M | -$200K | $900K | -- | |
Additions / Reductions | -$11.8M | $29.6M | -$7.9M | $12.1M | -- | |
Ending Cash (CF) | $370.2M | $377.5M | $176.1M | $140.3M | -- | |
Levered Free Cash Flow | $11M | $37.4M | -$700K | $34.8M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $56.5M | $150.8M | $31.8M | -$25.8M | $96.2M | |
Depreciation & Amoritzation | $62.5M | $57.8M | $55.9M | $51.1M | $67.3M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $10.5M | -$76.3M | $87.9M | -$63.2M | -$3.8M | |
Change in Inventories | $45.6M | -$2.6M | -$165.1M | $131.4M | -$145.9M | |
Cash From Operations | $169M | $131.2M | -$9.5M | $72M | $13.4M | |
Capital Expenditures | $58.3M | $47.8M | $63.2M | $52.1M | $36.8M | |
Cash Acquisitions | -- | -- | -- | -- | -$156.8M | |
Cash From Investing | -$58.3M | -$62M | -$65.3M | -$35.7M | -$193.6M | |
Dividends Paid (Ex Special Dividend) | -$83.2M | -$84.3M | -$87.8M | -$87.5M | -$39.1M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | $53.7M | $383.8M | |
Long-Term Debt Repaid | -$1.2M | -$1.4M | -$1.3M | -$53.5M | -$261M | |
Repurchase of Common Stock | -- | -$1.3M | -$2.6M | -$1.5M | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$84.4M | -$88.9M | -$91.8M | -$93.8M | $79.3M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $26.3M | -$19.7M | -$166.6M | -$57.5M | -$100.9M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $110.7M | $83.4M | -$72.7M | $19.9M | -$23.4M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $45.3M | $103.4M | -$23.4M | $27.6M | $18.1M | |
Depreciation & Amoritzation | $28.8M | $28.4M | $26.8M | $31.4M | $14.9M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$30.7M | -$58.6M | -$60.8M | -$81.6M | -$53.7M | |
Change in Inventories | $84.4M | -$30.3M | $71.2M | $100.2M | -$27.2M | |
Cash From Operations | $78.1M | $49.3M | -$76.6M | -$5.1M | -$102.4M | |
Capital Expenditures | $21.2M | $30.5M | $33.9M | $8.1M | $12M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$21.2M | -$30.4M | -$33.9M | -$8.1M | -$12M | |
Dividends Paid (Ex Special Dividend) | -$41.6M | -$43.9M | -$43.8M | -$43.7M | -$5.8M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | $53.7M | $145M | |
Long-Term Debt Repaid | -$400K | -$300K | -$400K | -$52.6M | -$112.1M | |
Repurchase of Common Stock | -- | -$1.1M | -$2.9M | -- | -- | |
Other Financing Activities | -$1.8M | -- | -- | -$5.8M | -- | |
Cash From Financing | -$43.8M | -$45.3M | -$47.1M | -$48.4M | $27.1M | |
Beginning Cash (CF) | $741.9M | $768.8M | $518.8M | $329.4M | $114.7M | |
Foreign Exchange Rate Adjustment | -$4.9M | -$8.7M | -$900K | -$200K | $1.2M | |
Additions / Reductions | $13.1M | -$26.4M | -$157.6M | -$61.6M | -$87.3M | |
Ending Cash (CF) | $750.1M | $733.7M | $360.3M | $267.6M | $28.6M | |
Levered Free Cash Flow | $56.9M | $18.8M | -$110.5M | -$13.2M | -$114.4M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.